A randomized trial of selenium supplementation and risk of type-2 diabetes, as assessed by plasma adiponectin.
Evidence that selenium affects the risk of type-2 diabetes is conflicting, with observational studies and a few randomized trials showing both lower and higher risk linked to the level of selenium intake and status. We investigated the effect of selenium supplementation on the risk of type-2 diabete...
Main Authors: | Margaret P Rayman, Gabrielle Blundell-Pound, Roberto Pastor-Barriuso, Eliseo Guallar, Holger Steinbrenner, Saverio Stranges |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3446875?pdf=render |
Similar Items
-
Selenium and cancer prevention
by: Rayman Margaret
Published: (2012-12-01) -
A prospective study of dietary selenium intake and risk of type 2 diabetes
by: Laclaustra Martin, et al.
Published: (2010-09-01) -
Selenium Supplementation and the Incidence of Preeclampsia in Pregnant Iranian Women: A Randomized, Double-Blind, Placebo-Controlled Pilot Trial
by: Fatemeh Tara, et al.
Published: (2010-06-01) -
Effect of Prenatal Selenium Supplementation on Cord Blood Selenium and Lipid Profile
by: Hassan Boskabadi, et al.
Published: (2012-12-01) -
Selenium Supplementation and Cardiovascular Outcome Markers in Hemodialysis Patients: A Randomized, Controlled Trial
Published: (2013)